180 related articles for article (PubMed ID: 24165853)
21. Characteristics of completed clinical trials for spinal cord injury from 1999 to 2020.
Onyedimma C; Moinuddin FM; Yolcu YU; Canoy Lllies AJ; El Sammak S; Trammell BC; Hunt CL; Qu W; Bydon M
J Clin Neurosci; 2021 Dec; 94():114-119. PubMed ID: 34863424
[TBL] [Abstract][Full Text] [Related]
22. Publication Rates of Registered Corneal Trials on ClinicalTrials.gov.
Cehelyk EK; Crespo MA; Syed ZA
Cornea; 2024 Mar; 43(3):356-359. PubMed ID: 37404122
[TBL] [Abstract][Full Text] [Related]
23. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
[TBL] [Abstract][Full Text] [Related]
24. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
Rees CA; Pica N; Monuteaux MC; Bourgeois FT
PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
Gianola S; Jesus TS; Bargeri S; Castellini G
PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
[TBL] [Abstract][Full Text] [Related]
26. Drug-drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study.
Jurić D; Bolić A; Pranić S; Marušić A
J Clin Epidemiol; 2020 Jan; 117():126-137. PubMed ID: 31654788
[TBL] [Abstract][Full Text] [Related]
27. How many US obstetrical trials reach publication? A cross-sectional analysis of ClinicalTrials.gov and PubMed from 2007 to 2019.
DiTosto JD; Steinberg JR; Turner BE; Weeks BT; Young AMP; Lu CF; Wolgemuth T; Holder K; Laasiri N; Squires NA; Anderson JN; Zhang N; Richardson MT; Magnani CJ; Perry MF; Yee LM
Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100696. PubMed ID: 35872356
[TBL] [Abstract][Full Text] [Related]
28. Reporting of the safety from allergic rhinitis trials registered on ClinicalTrials.gov and in publications: An observational study.
Paladin I; Pranić SM
BMC Med Res Methodol; 2022 Oct; 22(1):262. PubMed ID: 36199040
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting publication of spinal cord injury trials registered on www.ClinicalTrials. gov.
DePasse JM; Park S; Eltorai AEM; Daniels AH
J Back Musculoskelet Rehabil; 2018 Feb; 31(1):45-48. PubMed ID: 28826165
[TBL] [Abstract][Full Text] [Related]
30. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
31. Publication of Results of Registered Trials With Published Study Protocols, 2011-2022.
Vorland CJ; Brown AW; Kilicoglu H; Ying X; Mayo-Wilson E
JAMA Netw Open; 2024 Jan; 7(1):e2350688. PubMed ID: 38190185
[TBL] [Abstract][Full Text] [Related]
32. Early Discontinuation, Results Reporting, and Publication of Pediatric Clinical Trials.
Brewster R; Wong M; Magnani CJ; Gunningham H; Hoffer M; Showalter S; Tran K; Steinberg JR; Turner BE; Goodman SN; Schroeder AR
Pediatrics; 2022 Apr; 149(4):. PubMed ID: 35314864
[TBL] [Abstract][Full Text] [Related]
33. Publication of interventional phase 3 and 4 clinical trials in radiation oncology: an observational study.
Pérez-Alija J; Gallego P; Linares I; Ambroa E; Pedro A
BMJ Open; 2017 Sep; 7(9):e016040. PubMed ID: 28939574
[TBL] [Abstract][Full Text] [Related]
34. Research without results: inadequate public reporting of clinical trial results.
Gopal RK; Yamashita TE; Prochazka AV
Contemp Clin Trials; 2012 May; 33(3):486-91. PubMed ID: 22342449
[TBL] [Abstract][Full Text] [Related]
35. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
[TBL] [Abstract][Full Text] [Related]
36. Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles.
Pranić S; Marušić A
J Clin Epidemiol; 2016 Feb; 70():26-37. PubMed ID: 26226103
[TBL] [Abstract][Full Text] [Related]
37. Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials.
Hakala A; Kimmelman J; Carlisle B; Freeman G; Fergusson D
BMJ; 2015 Mar; 350():h1116. PubMed ID: 25752879
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of studies of pharmacist services registered in ClinicalTrials.gov.
Dammo N; Harpe SE
J Am Pharm Assoc (2003); 2020; 60(4):609-617. PubMed ID: 31902662
[TBL] [Abstract][Full Text] [Related]
39. Publication Rates of Heart Failure Clinical Trials Remain Low.
Psotka MA; Latta F; Cani D; Fiuzat M; Sbolli M; Barnett S; Metra M; O'Connor CM
J Am Coll Cardiol; 2020 Jun; 75(25):3151-3161. PubMed ID: 32586589
[TBL] [Abstract][Full Text] [Related]
40. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles.
Tang E; Ravaud P; Riveros C; Perrodeau E; Dechartres A
BMC Med; 2015 Aug; 13():189. PubMed ID: 26269118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
